Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis

This publication has 24 references indexed in Scilit:

• Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression
  HIV Research & Clinical Practice, 2008
• Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance
  AIDS, 2008
• Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance
  Journal of the International AIDS Society, 2008
• A Lopinavir/Ritonavir-Based Once-Daily Regimen Results in Better Compliance and Is Non-inferior to a Twice-Daily Regimen Through 96 Weeks
  AIDS Research and Human Retroviruses, 2007
• Pillbox Organizers are Associated with Improved Adherence to HIV Antiretroviral Therapy and Viral Suppression: a Marginal Structural Model Analysis
  Clinical Infectious Diseases, 2007
• Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
  AIDS, 2007
• Pilot Study of Once-Daily Simplification Therapy with Abacavir/Lamivudine/Zidovudine and Efavirenz for Treatment of HIV-1 Infection
  HIV Research & Clinical Practice, 2006
• Durability of Adherence to Antiretroviral Therapy on Initial and Subsequent Regimens
  AIDS Patient Care and STDs, 2006
• Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral Therapy
  Clinical Infectious Diseases, 2004
• Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical Trial
  The Journal of Infectious Diseases, 2004